Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 138,838 | 205,991 | 183,771 | 189,396 | 174,935 |
| Receivables | 265,737 | 248,738 | 258,380 | 272,260 | 251,799 |
| Inventories | 280,347 | 290,846 | 290,517 | 290,474 | 296,332 |
| TOTAL | $775,082 | $827,983 | $821,322 | $848,650 | $822,146 |
| Non-Current Assets | |||||
| PPE Net | 300,112 | 287,000 | 277,025 | 274,029 | 269,251 |
| Intangibles | 2,005,971 | 2,023,628 | 2,048,993 | 2,092,449 | 2,097,532 |
| Other Non-Current Assets | 26,722 | 40,031 | 38,433 | 32,565 | 22,328 |
| TOTAL | $2,332,805 | $2,350,659 | $2,364,451 | $2,399,043 | $2,389,111 |
| Total Assets | $3,107,887 | $3,178,642 | $3,185,773 | $3,247,693 | $3,211,257 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 60,000 | N/A |
| Accounts payable and accrued liabilities | 76,050 | 86,380 | 84,037 | 86,995 | 93,967 |
| Accrued Expenses | 160,238 | 155,710 | 144,405 | 164,810 | 161,100 |
| Other current liabilities | 3,764 | 5,000 | 4,900 | 24,215 | 22,793 |
| TOTAL | $262,552 | $258,340 | $233,342 | $336,020 | $348,911 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,210,513 | 1,421,001 | 1,476,488 | 1,772,027 | 1,781,142 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 11,051 |
| Other Non-Current Liabilities | 201,248 | 61,223 | 60,727 | 68,327 | 53,768 |
| TOTAL | $1,469,539 | $1,555,221 | $1,610,526 | $1,913,233 | $1,900,040 |
| Total Liabilities | $1,732,091 | $1,813,561 | $1,843,868 | $2,249,253 | $2,248,951 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,229 | 85,180 | 85,132 | 78,948 | 78,494 |
| Common Shares | 880 | 880 | 877 | 817 | 813 |
| Retained earnings | 348,373 | 323,236 | 309,941 | 297,500 | 285,186 |
| Other shareholders' equity | -45,058 | -25,998 | -25,038 | -1,397 | -23,451 |
| TOTAL | $1,375,796 | $1,365,081 | $1,341,905 | $998,440 | $962,306 |
| Total Liabilities And Equity | $3,107,887 | $3,178,642 | $3,185,773 | $3,247,693 | $3,211,257 |